Name: First Choice Neurology
Price range: $$$

BAN2401 Phase 3 Clinical Trial Starting April 2019

medical news / March 19, 2019 March 22, 2019

We are enthusiastic about the results of the BAN2401 phase 2 clinical trial for dementia. The study assessed changes from baseline to 18 months in biomarkers measuring the underlying disease …

BAN2401 Phase 3 Clinical Trial Starting April 2019 Read More »

BAN2401 Clinical Trial

BAN2401 Study to Assess New Alzheimer’s Treatment

BAN2401 Phase 3 Clinical Trial Starting April 2019

MEDICAL SERVICES

QUICK LINKS

RESOURCES